within Pharmacolibrary.Drugs.ATC.C;

model C08DA01_1
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0005600000000000001,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0029,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0044800000000000005,
    k12             = 24,
    k21             = 24
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C08DA01_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Verapamil is a calcium channel blocker used therapeutically to treat hypertension, angina pectoris, and certain arrhythmias such as supraventricular tachycardia. It is approved for use and remains in clinical use today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters after intravenous bolus administration in healthy adult males.</p><h4>References</h4><ol><li><p>Toffoli, G, et al., &amp; Boiocchi, M (1997). Non-linear pharmacokinetics of high-dose intravenous verapamil. <i>British journal of clinical pharmacology</i> 44(3) 255–260. DOI:<a href=\"https://doi.org/10.1046/j.1365-2125.1997.t01-1-00574.x\">10.1046/j.1365-2125.1997.t01-1-00574.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9296319/\">https://pubmed.ncbi.nlm.nih.gov/9296319</a></p></li><li><p>Hamann, SR, et al., &amp; McAllister, RG (1984). Clinical pharmacokinetics of verapamil. <i>Clinical pharmacokinetics</i> 9(1) 26–41. DOI:<a href=\"https://doi.org/10.2165/00003088-198409010-00002\">10.2165/00003088-198409010-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6362951/\">https://pubmed.ncbi.nlm.nih.gov/6362951</a></p></li><li><p>Eichelbaum, M, et al., &amp; Vogelgesang, B (1984). Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration. <i>British journal of clinical pharmacology</i> 17(4) 453–458. DOI:<a href=\"https://doi.org/10.1111/j.1365-2125.1984.tb02371.x\">10.1111/j.1365-2125.1984.tb02371.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6721991/\">https://pubmed.ncbi.nlm.nih.gov/6721991</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C08DA01_1;
